Monopar Therapeutics shares owned by Tower Research Capital
Quarter-by-quarter ownership of Monopar Therapeutics (MNPR) shares owned by Tower Research Capital
from 13F filings
Historical chart of Tower Research Capital investment in Monopar Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Monopar Therapeutics held by Tower Research Capital consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Monopar Therapeutics by Tower Research Capital
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-06-30 | $5.8k | 7.9k | 0.73 |
| 2024-03-31 | $5.3k | 7.9k | 0.68 |
| 2023-09-30 | $2.3k | 3.7k | 0.62 |
| 2023-06-30 | $3.2k | 3.7k | 0.86 |
| 2023-03-31 | $999 | 713 | 1.40 |
| 2022-12-31 | $7.0k | 2.8k | 2.47 |
| 2022-09-30 | $5.0k | 3.1k | 1.60 |
| 2022-06-30 | $5.0k | 2.4k | 2.11 |
| 2022-03-31 | $9.0k | 3.6k | 2.53 |
| 2021-12-31 | $8.0k | 2.4k | 3.33 |
| 2021-03-31 | $14k | 2.2k | 6.33 |
| 2020-12-31 | $9.0k | 1.4k | 6.41 |
| 2020-09-30 | $25k | 4.7k | 5.32 |
| 2020-03-31 | $0 | 68 | 0.00 |
Top funds holding Monopar Therapeutics
View all funds holding Monopar Therapeutics